Golden State Equity Partners’s iShares MSCI ACWI ETF ACWI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$37K Sell
235
-73
-24% -$11.2K 0.1% 122
2026
Q1
$42.7K Buy
+308
New +$44.3K ﹤0.01% 921
2024
Q3
Sell
-2,628
Closed -$295K 816
2024
Q2
$295K Buy
+2,628
New +$289K 0.06% 324
2023
Q4
$271K Sell
2,667
-55
-2% -$5.26K 0.07% 303
2023
Q3
$251K Buy
2,722
+454
+20% +$43.6K 0.07% 283
2023
Q2
$218K Buy
2,268
+9
+0.4% +$835 0.06% 333
2023
Q1
$206K Buy
+2,259
New +$202K 0.11% 199
2022
Q1
$271K Buy
2,711
+252
+10% +$25.1K 0.14% 156
2021
Q4
$260K Buy
2,459
+35
+1% +$3.66K 0.13% 143
2021
Q3
$242K Buy
2,424
+116
+5% +$11.9K 0.1% 197
2021
Q2
$234K Buy
2,308
+6
+0.3% +$598 0.09% 213
2021
Q1
$219K Hold
2,302
0.13% 156
2020
Q4
$208K Buy
+2,302
New +$197K 0.14% 162

Other funds holding ACWI

Golden State Equity Partners's ACWI Position: Q2 2026 in Review

Golden State Equity Partners reduced its iShares MSCI ACWI ETF (ACWI) stake by 24% in Q2 2026, selling an estimated $11.2K and leaving 235 shares worth $37K. The position accounts for 0.1% of the portfolio, ranked #122.

Golden State Equity Partners first reported a position in ACWI in Q4 2020 and has held it in 13 quarters since. The position peaked at $295K in Q2 2024. 841 funds tracked by Wall St. Rank hold ACWI as of Q2 2026.

  • Golden State Equity Partners held 235 shares of iShares MSCI ACWI ETF worth $37K as of Q2 2026.
  • Golden State Equity Partners sold 73 iShares MSCI ACWI ETF shares in Q2 2026, an estimated $11.2K.
  • iShares MSCI ACWI ETF made up 0.1% of Golden State Equity Partners's portfolio in Q2 2026, its #122 holding.
  • Golden State Equity Partners first reported a position in iShares MSCI ACWI ETF in Q4 2020 and has held it in 13 quarters since.
  • Golden State Equity Partners's iShares MSCI ACWI ETF position peaked at $295K in Q2 2024.
  • 841 funds tracked by Wall St. Rank held iShares MSCI ACWI ETF as of Q2 2026.

Based on Golden State Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.